Adc Therapeutics SA (ADCT) — DEF 14A Filings
All DEF 14A filings from Adc Therapeutics SA. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
ADC Therapeutics SA Files Definitive Proxy Statement
— Apr 21, 2025 Risk: low
ADC Therapeutics SA filed a definitive proxy statement (DEF 14A) on April 21, 2025, for its annual meeting on June 3, 2025. The filing outlines the company's go -
ADC Therapeutics SA Files 2024 Proxy Statement
— Sep 23, 2024 Risk: low
ADC Therapeutics SA filed a definitive proxy statement (DEF 14A) on September 23, 2024, for its annual general meeting. The filing concerns the company's govern -
ADC Therapeutics SA Announces 2024 Annual General Meeting of Shareholders
— Apr 26, 2024 Risk:
ADC Therapeutics SA (ADCT) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. The 2024 Annual General Meeting of Shareholders for ADC Therapeutic
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX